Papers
16
Total Citations
276
H-Index
11
About
Nelia Amigoni is a urological researcher whose work centers on robotic-assisted radical prostatectomy (RARP), extended pelvic lymph node dissection (ePLND), and surgical outcomes in prostate cancer management. With a body of research spanning surgical oncology and perioperative risk stratification, Amigoni has made significant contributions to understanding how patient characteristics — particularly obesity and body mass index — influence surgical complications, lymph node metastasis, and oncological outcomes. Her most cited work (39 citations) established BMI as an independent predictor of serious complications following RARP with ePLND, while subsequent studies revealed obesity's role in predicting clinically undetected lymph node metastases in intermediate- and high-risk patients. Amigoni has also advanced anatomical knowledge of lymph node dissection, notably investigating the oncological relevance of Cloquet's nodes and Marcille's fossa — the latter coining the term "Marcillectomy" for targeted dissection. Her analyses of positive surgical margins, hospital readmission risk, and comparative open versus robotic approaches, drawn from large institutional cohorts of over 1,000 patients, underscore her commitment to evidence-based surgical refinement. Collectively, her research offers clinicians practical, data-driven guidance for optimizing prostate cancer surgery outcomes.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10